Funds and ETFs Stereotaxis, Inc.

Equities

STXS

US85916J4094

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 17:20:53 14/05/2024 BST 5-day change 1st Jan Change
2.13 USD -1.39% Intraday chart for Stereotaxis, Inc. -5.33% +21.71%
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.16 USD
Average target price
4.5 USD
Spread / Average Target
+108.33%
Consensus
  1. Stock Market
  2. Equities
  3. STXS Stock
  4. Funds and ETFs Stereotaxis, Inc.